161 related articles for article (PubMed ID: 18278176)
1. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
Kanse SM; Parahuleva M; Muhl L; Kemkes-Matthes B; Sedding D; Preissner KT
Thromb Haemost; 2008 Feb; 99(2):286-9. PubMed ID: 18278176
[TBL] [Abstract][Full Text] [Related]
2. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
Sedding D; Daniel JM; Muhl L; Hersemeyer K; Brunsch H; Kemkes-Matthes B; Braun-Dullaeus RC; Tillmanns H; Weimer T; Preissner KT; Kanse SM
J Exp Med; 2006 Dec; 203(13):2801-7. PubMed ID: 17145954
[TBL] [Abstract][Full Text] [Related]
3. The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.
Wasmuth HE; Tag CG; Van de Leur E; Hellerbrand C; Mueller T; Berg T; Puhl G; Neuhaus P; Samuel D; Trautwein C; Kanse SM; Weiskirchen R
Hepatology; 2009 Mar; 49(3):775-80. PubMed ID: 19105210
[TBL] [Abstract][Full Text] [Related]
4. Factor VII activating protease. Single nucleotide polymorphisms light the way.
Kanse SM; Etscheid M
Hamostaseologie; 2011 Aug; 31(3):174-6, 177-8. PubMed ID: 21655671
[TBL] [Abstract][Full Text] [Related]
5. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease.
Muhl L; Galuska SP; Oörni K; Hernández-Ruiz L; Andrei-Selmer LC; Geyer R; Preissner KT; Ruiz FA; Kovanen PT; Kanse SM
FEBS J; 2009 Sep; 276(17):4828-39. PubMed ID: 19664058
[TBL] [Abstract][Full Text] [Related]
6. Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells.
Kannemeier C; Al-Fakhri N; Preissner KT; Kanse SM
FASEB J; 2004 Apr; 18(6):728-30. PubMed ID: 14977886
[TBL] [Abstract][Full Text] [Related]
7. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM
Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531
[TBL] [Abstract][Full Text] [Related]
8. Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.
Daniel JM; Reichel CA; Schmidt-Woell T; Dutzmann J; Zuchtriegel G; Krombach F; Herold J; Bauersachs J; Sedding DG; Kanse SM
J Thromb Haemost; 2016 Oct; 14(10):2058-2067. PubMed ID: 27431088
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation.
Shibamiya A; Muhl L; Tannert-Otto S; Preissner KT; Kanse SM
Biochem J; 2007 May; 404(1):45-50. PubMed ID: 17300216
[TBL] [Abstract][Full Text] [Related]
10. Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells.
Byskov K; Boettger T; Ruehle PF; Nielsen NV; Etscheid M; Kanse SM
Atherosclerosis; 2017 Oct; 265():133-139. PubMed ID: 28881271
[TBL] [Abstract][Full Text] [Related]
11. Factor VII activating protease.
Kanse SM; Etscheid M
Hamostaseologie; 2011; 31(3):174-178. PubMed ID: 29589358
[TBL] [Abstract][Full Text] [Related]
12. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells.
Roderfeld M; Weiskirchen R; Atanasova S; Gressner AM; Preissner KT; Roeb E; Kanse SM
Liver Int; 2009 May; 29(5):686-91. PubMed ID: 19018983
[TBL] [Abstract][Full Text] [Related]
13. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.
Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J
Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747
[TBL] [Abstract][Full Text] [Related]
14. Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP).
Subramaniam S; Thielmann I; Morowski M; Pragst I; Sandset PM; Nieswandt B; Etscheid M; Kanse SM
Thromb Haemost; 2015 Apr; 113(4):870-80. PubMed ID: 25427855
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PDGF-BB by Factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP.
Muhl L; Nykjaer A; Wygrecka M; Monard D; Preissner KT; Kanse SM
Biochem J; 2007 Jun; 404(2):191-6. PubMed ID: 17298300
[TBL] [Abstract][Full Text] [Related]
16. The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).
Roemisch J; Feussner A; Nerlich C; Stoehr HA; Weimer T
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):433-41. PubMed ID: 12138371
[TBL] [Abstract][Full Text] [Related]
17. Regulation of monocyte/macrophage function by factor VII activating protease (FSAP).
Parahuleva MS; Maj R; Hölschermann H; Parviz B; Abdallah Y; Erdogan A; Tillmanns H; Kanse SM
Atherosclerosis; 2013 Oct; 230(2):365-72. PubMed ID: 24075769
[TBL] [Abstract][Full Text] [Related]
18. Factor VII-Activating Protease: Hemostatic Protein or Immune Regulator?
Zeerleder S
Semin Thromb Hemost; 2018 Mar; 44(2):151-158. PubMed ID: 29172215
[TBL] [Abstract][Full Text] [Related]
19. Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.
Kanse SM; Declerck PJ; Ruf W; Broze G; Etscheid M
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):427-33. PubMed ID: 22116096
[TBL] [Abstract][Full Text] [Related]
20. Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.
Sidelmann JJ; Skouby SO; Kluft C; Winkler U; Vitzthum F; Schwarz H; Gram J; Jespersen J
Thromb Res; 2011 Nov; 128(5):e67-72. PubMed ID: 21737124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
